Skip to main content
SpringerLink
Log in

Selective Ligands for Benzodiazepine Receptors: Recent Developments

  • Chapter
Current Aspects of the Neurosciences

Abstract

We are all familiar with the term benzodiazepine, as are a significant proportion of the general public. In the public domain it is a term synonymous with diazepam that connotes dependence and withdrawal. The scientific community also has its misconceptions about the term benzodiazepine, which is perhaps not surprising given the speed of evolution of our knowledge about these drugs, their receptors and the uniqueness of their pharmacology. In no other field of CNS pharmacology has such a short time elapsed between the discovery of a receptor and its cloning and expression. It is at times hard to believe that the first report of brain-specific benzodiazepine receptors was made only 12 years ago (Squires and Braestrup, 1977; Mohler and Okada, 1978). Not surprisingly, some of the more recent and novel aspects of benzodiazepine pharmacology have not yet been fully assimilated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adinoff, B., Majchrowicz, E., Martin, P. R. and Linnoila, M. (1986). The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome. Biol. Psychiat., 21, 643–649

    Article  PubMed  CAS  Google Scholar 

  • Ahlquist, R. P. (1948). A study of adrenotropic receptors. Am. J. Physiol., 153, 586–600

    PubMed  CAS  Google Scholar 

  • Airaksinen, M. M. and Kari, I. (1981). Beta-carbolines, psychoactive compounds in the mammalian body. Med. Biol., 59, 21–34

    PubMed  CAS  Google Scholar 

  • Allan, A. M. and Harris, R. A. (1986). Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes. J. Pharmacol. Exp. Ther., 238, 763–768

    PubMed  CAS  Google Scholar 

  • Alon, E., Baitella, L. and Hossli, G. (1987). Double blind study of the reversal of midazolam-supplemented general anaesthesia with Ro 15-1788. Br. J. Anaes., 59, 455–458

    Article  CAS  Google Scholar 

  • Arbilla, S., Depoortere, H., George, P. and Langer, S. Z. (1985). Pharmacological profile of the Imidazopyridine Zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn-Schmiedeberg’s Arch. Pharmacol., 330, 248–251

    Article  CAS  Google Scholar 

  • Atterwill, C. K. and Nutt, D. J. (1983). Thyroid hormones do not alter rat brain benzodiazepine receptor function in vivo. J. Pharm. Pharmacol., 35, 767–768

    Article  PubMed  CAS  Google Scholar 

  • Baraldi, M., Zeneroli, M. L., Ventura, E., Penne, A., Pinelli, G., Ricci, P. and Santi, M. (1984). Supersensitivity of benzodiazepine receptors in hepatic encephalography due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clinical Science, 67, 167–175

    Article  PubMed  CAS  Google Scholar 

  • Barbaccia, M. C., Costa, E., Ferrero, P., Guidotti, A., Roy, A., Sunderland, T., Pickar, D., Paul, S. M. and Goodwin, F. K. (1986). Diazepam binding inhibitor. Arch. Gen. Psychiat., 43, 1143–1147

    Article  PubMed  CAS  Google Scholar 

  • Bennett, D. A. (1987). Pharmacology of the pyrazolo-type compounds: agonist, antagonist and inverse agonist actions. Physiol Behav., 41, 241–245

    Article  PubMed  CAS  Google Scholar 

  • Bernard, P. S., Bennett, D. A., Pastor, G., Yokoyoma, N. and Liebman, J. M. (1985). CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents. J. Pharmacol. Exp. Ther., 235, 98–105

    PubMed  CAS  Google Scholar 

  • Bhattacharya, S. K., Glover, V., Sandler, M., Clow, A., Topham, A., Bernadt, M. and Murray, R. (1982). Raised endogenous monoamine oxidase inhibitor output in post withdrawal alcoholics: effects of L-dopa and ethanol. Biol. Psychiat., 17, 687–694

    Google Scholar 

  • Bieck, P. R., Antonin, K. H., Britzelmeier, C., Cremer, C., Gleiter, C., Nilsson, E. and Schoenleber, W. (1984). Human pharmacology of CGS 8216, a benzodiazepine antagonist. Clinical Neuropharmacol., 7, 674–675

    Article  Google Scholar 

  • Biggio, G., Concas, A., Corda, M. G. and Serra, M. (1989). Enhancement of GABAergic transmission by Zolpidem, an Imidazopyridine with preferential affinity for type 1 benzodiazepine receptors. Eur. J. Pharmacol., 161, 173–180

    Article  PubMed  CAS  Google Scholar 

  • Billard, W., Crosby, G., Iorio, L., Chipkin, R. and Barnett, A. (1988). Selective affinity of the benzodiazepine quazepam and 2-oxo-quazepam for BZ1 binding site and demonstration of 3H-2-oxo-quazepam as a BZ1 selective radioligand. Life Sci., 42, 179–187

    Article  PubMed  CAS  Google Scholar 

  • Biscoe, T. J., Duchen, M. R., Fry, J. P. and Rickets, C. (1989). Purification and action of endogenous benzodiazepine-like immuno-reactivity isolated from the brain of the mouse. Proc. Physiol. Soc., U.C.L. Meeting, April, 53 (abstract)

    Google Scholar 

  • Biziere, K., Bourguignon, J. J., Chambon, J. P., Heaulme, M., Perio, A., Tebib, S. and Wermuth, C. G. (1987). A 7-phenyl substituted triazolopyridazine has inverse agonist activity at the benzodiazepine receptor site. Br. J. Pharmacol., 90, 183–190

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Blair, L. A. C., Levitan, E. S., Marshall, J., Dionne, V. E. and Barnard, E. A. (1988). Single subunits of the GABAA receptor form ion channels with properties of the native receptor. Science, 242, 577–579

    Article  PubMed  CAS  Google Scholar 

  • Bonetti, E. P., Burkard, W. P., Gabl, M., Hunkeler, W., Lorez, H.-P., Martin, J. R., Moehler, H., Osterrieder, W., Pieri, L., Polc, P., Richards, J. G., Schaffner, R., Scherschlicht, R., Schoch, P. and Haefely, W. E. (1989). Ro 15-4513: partial inverse agonism at the BZR and interaction with ethanol. Pharmacol. Biochem. Behav., 31, 733–749

    Article  Google Scholar 

  • Bonetti, E. P., Pieri, L., Cumin, R., Schaffner, R., Pieri, M., Gamzu, E. R., Muller, R. K. M. and Haefely, W. (1982). Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology, 78, 8–18

    Article  PubMed  CAS  Google Scholar 

  • Braestrup, C. and Nielsen, M. (1980). Searching for endogenous benzodiazepine receptor ligands. TIPS, November, 424–427

    Google Scholar 

  • Braestrup, C., Nielsen, M., Honore, T., Jensen, L. H. and Petersen, E. N. (1983). Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology, 22, 1451–1457

    Article  PubMed  CAS  Google Scholar 

  • Braestrup, C., Nielsen, M. and Olsen, C. E. (1980). Urinary and brain b-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc. Natl Acad. Sci. USA, 77, 2288–2292

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Brain Research Bulletin—Meeting Report (1987). Bidirectional effects of β-carbolines in behavioral pharmacology. Brain Res. Bull., 19, 291-end

    Article  Google Scholar 

  • Brogden, R. N. and Goa, K. L. (1988). Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs, 35, 448–467

    Article  PubMed  CAS  Google Scholar 

  • Brown, C. L. and Martin, I. L. (1983). Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy. Neurosci. Lett., 35, 37–40

    Article  PubMed  CAS  Google Scholar 

  • Burch, T. P. and Ticku, M. K. (1981). Histidine modification with diethyl pyrocarbonate shows heterogeneity of benzodiazepine receptors. Proc. Natl Acad. Sci. USA, 78, 3945–3949

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Burkard, W. P., Bonetti, E. P. and Haefely, W. (1985). The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice. Eur. J. Pharmacol., 109, 241–247

    Article  PubMed  CAS  Google Scholar 

  • Burr, W., Sandham, P. and Judd, A. (1989). Death after flumazenil. BMJ, 298, letters, 1713

    Google Scholar 

  • Clow, A., Glover, V., Armando, I. and Sandler, M. (1983). New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sci., 33, 735–741

    PubMed  CAS  Google Scholar 

  • Clow, A., Glover, V., Sandler, M. and Tiller, J. (1988). Increased urinary tribulin output in generalised anxiety disorder. Psychopharmacol., 95, 378–380

    Article  CAS  Google Scholar 

  • Codding, P. W. and Muir, A. K. S. (1985). Molecular structure of Ro 15-1788 and a model for the binding of benzodiazepine receptor ligands. Mol. Pharmacol., 28, 178–184

    PubMed  CAS  Google Scholar 

  • Concas, A., Serra, M., Crisponi, G., Nurchi, V., Corda, M. G. and Biggio, G. (1985). Changes in the characteristics of low affinity GABA binding sites elicited by Ro 15-1788. Life Sci., 36, 329–337

    Article  PubMed  CAS  Google Scholar 

  • Corda, M. G., Giorgi, O., Longoni, B., Ongini, E., Montaldo, S. and Biggio, G. (1988). Preferential affinity of 3H-2-oxo-quazepam for type 1 benzodiazepine recognition sites in the human brain. Life Sci., 42, 189–197

    Article  PubMed  CAS  Google Scholar 

  • Cowen, P. J., Green, A. R., Martin, I. L. and Nutt, D. J. (1981). Ethyl-b-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats. Nature, 290, 54–55

    Article  PubMed  CAS  Google Scholar 

  • Cumin, R., Bonetti, E. P., Scherschlicht, R. and Haefely, W. E. (1982). Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines. Experientia, 38, 833–834

    Article  PubMed  CAS  Google Scholar 

  • Czernik, A. J., Petrack, B., Kalinsky, H. J., Psychoyos, S., Cash, W. D., Tsai, C., Rinehart, R. K., Granat, F. R., Lovell, R. A., Brundish, D. E. and Wade, R. (1982). CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist. Life Sci., 30, 363–372

    Article  PubMed  CAS  Google Scholar 

  • Davidson, J., Glover, V., Clow, A., Kudler, H., Meador, K. and Sandler, M. (1988). Tribulin in post-traumatic stress disorder. Psychol. Med., 4, 833–836

    Article  Google Scholar 

  • Davis, L. G. and Cohen, R. K. (1980). Identification of an endogenous peptide-ligand for the benzodiazepine receptor. Biochem. Biophys. Res. Commun., 92, 141–148

    Article  PubMed  CAS  Google Scholar 

  • De Blas, A. L. (1988). Diazepam and N-desmethyldiazepam in plant food and in brain. Tins, 11, 489–490

    PubMed  Google Scholar 

  • De Deyn, P. P. and Macdonald, R. L. (1987). CGS 9896 and ZK 91296, but not CGS 8216 and RO 15-1788, are pure benzodiazepine receptor antagonists on mouse neurons in culture. J. Pharmacol. Exp. Ther., 2421, 48–55

    Google Scholar 

  • Deckert, J., Kuhn, W. and Przuntek, H. (1984). Endogenous benzodiazepine ligands in human cerebrospinal fluid. Peptides, 5, 641–644

    Article  PubMed  CAS  Google Scholar 

  • Deckert, J., Estall, L. B., Marangos, P. J. and Cooper, S. J. (1987). CGS 8216 treatment decreases central-type benzodiazepine receptors in rat brain. Eur. J. Pharmacol., 142, 457–460

    Article  PubMed  CAS  Google Scholar 

  • Dellouve-Courillon, C., Lambolez, B., Potier, P. and Dodd, R. H. (1989). The use of a β-carboline as photoaffinity label for the benzodiazepine receptor. Eur. J. Pharmacol., 166, 557–562

    Article  PubMed  CAS  Google Scholar 

  • Dodd, R. H., Ouannes, C., Prado de Carvalho, L., Valin, A., Venault, P., Chapouthier, G., Rossier, J. and Potier, P. (1985). 3-amino-β-carboline derivatives and the benzodiazepine receptor. Synthesis of selective antagonist of the sedative action of diazepam. J. Med. Chem., 28, 824

    Article  PubMed  CAS  Google Scholar 

  • Dorow, R., Horowski, R., Paschelke, G., Amin, M. and Braestrup, C. (1983). Severe anxiety induced by FG 7142, a b-carboline ligand for benzodiazepine receptors. Lancet, 2, 98–99

    Article  PubMed  CAS  Google Scholar 

  • Dorow, R., Duka, T., Sauerbrey, N. and Holler, L. (1987). (beta)-carbolines: new insights into the clinical pharmacology of benzodiazepine receptor ligands. In Clinical Pharmacology in Psychiatry (ed. S. G. Dahl, L. F. Gram, S. M. Paul and W. Z. Potter), Springer, Berlin-Heidelberg, pp. 37–51

    Google Scholar 

  • Duka, T., Goerke, D., Dorow, R., Holler, L. and Fichte, K. (1988). Human studies on the benzodiazepine receptor antagonist β-carboline ZK 93-426. Psychopharmacology, 95, 463–471

    Article  PubMed  CAS  Google Scholar 

  • Ehlert, F. J., Roeske, W. R. and Yamamura, H. I. (1981). Multiple benzodiazepine receptors and their regulation by (gamma)-aminobutyric acid. Life Sci., 29, 235–248

    Article  PubMed  CAS  Google Scholar 

  • Ennis, C. and Minchin, M. C. W. (1988). Modulation of the GABA autoreceptor by benzodiazepine receptor ligands. Neuropharmacol., 27, 1003–1006

    Article  CAS  Google Scholar 

  • Evoniuk, G. and Skolnick, P. (1988). Anion regulation of agonist and inverse agonist binding to benzodiazepine receptors. J. Neurochem., 51, 1169–1175

    Article  PubMed  CAS  Google Scholar 

  • Farb, D. H., Borden, L. A., Chan, C. T., Czajkowski, C. M., Gibbs, T. T. and Schiller, G. D. (1984). Modulation of neuronal function through benzodiazepine receptors: biochemical and electrophysiological studies of neurons in primary monolayer cell culture. Ann. N.Y. Acad. Sci., 435, 1–31

    Article  PubMed  CAS  Google Scholar 

  • Feely, M., Boyland, P., Picardo, A., Cox, A. and Paul Gent, J. (1989). Lack of anticonvulsant tolerance with RU 32698 and Ro 17-1812. Eur. J. Pharmacol., 164, 377–380

    Article  PubMed  CAS  Google Scholar 

  • Ferrarese, C., Alho, H., Guidotti, A. and Costa, E. (1987). Co-localization and co-release of GABA and putative allosteric modulators of GABA receptor. Neuropharmacology, 6621, 1011–1088

    Article  Google Scholar 

  • Ferrero, P., Guidotti, A., Conti-Tronconi, B. and Costa, E. (1984). A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacol., 23, 1359–1362

    Article  CAS  Google Scholar 

  • Ferrero, P., Santi, M., Canti-Tronconi, B., Costa, E. and Guidotti, A. (1986). Study of an octadecaneuropeptide derived from DBI: biological activity and presence in rat brain. Proc. Natl Acad. Sci., USA, 83, 827–831

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • File, S. E. (1982). Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance. Psychopharmacology, 77, 284–288

    Article  PubMed  CAS  Google Scholar 

  • File, S. E. (1983). Proconvulsant action of CGS 8216. Neurosci. Lett., 35, 317–320

    Article  PubMed  CAS  Google Scholar 

  • File, S. E. and Pellow, S. (1986). Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology, 88, 1–11

    Article  PubMed  CAS  Google Scholar 

  • File, S. E., Lister, R. G. and Nutt, D. J. (1982a). The anxiogenic action of benzodiazepine antagonists. Neuropharmacology, 21, 1022–1037

    Google Scholar 

  • File, S. E., Lister, R. G. and Nutt, D. J. (1982b). Intrinsic action of benzodiazepine antagonists. Neurosci. Lett., 32, 165–168

    Article  PubMed  CAS  Google Scholar 

  • File, S. E. and Pellow, S. (1988). Low and high doses of benzodiazepine receptor inverse agonists respectively improve and impair performance in passive avoidance but do not affect habituation. Behav. Brain Res., 293, 57–68

    Google Scholar 

  • Friedl, W., Hebebrand, J., Rabe, S. and Propping, P. (1988). Phylogenetic conservation of the benzodiazepine binding sites: pharmacological evidence. Neuropharmacol., 27, 163–170

    Article  CAS  Google Scholar 

  • Gallager, D. W., Heninger, K. and Heninger, G. (1986). Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. Eur. J. Pharmacol., 132, 31–38

    Article  PubMed  CAS  Google Scholar 

  • Gallaher, E. J., Hollister, L. E., Gionet, S. E. and Crabbe, J. C. (1987). Mouse Unes selected for genetic differences in diazepam sensitivity. Psychopharmacol., 93, 25–30

    Article  CAS  Google Scholar 

  • Gardner, C. R. (1988). Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum. Prog. Neurobio., 31, 425–476

    Article  CAS  Google Scholar 

  • Gardner, C. R., Deacon, R., James, V., Parker, F. and Budhram, P. (1987). Agonist and antagonist activities at benzodiazepine receptors of a novel series of quinoline derivatives. Eur. J. Pharmacol., 142, 285–295

    Article  PubMed  CAS  Google Scholar 

  • Gath, I., Weidenfeld, J., Collins, G. I. and Hadad, H. (1984). Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505. Br. J. Clin. Pharmacol., 18, 541–547

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gee, K. W., Ehlert, F. J. and Yamamura, H. I. (1982). The influence of temperature and gamma-aminobutyric acid on benzodiazepine receptor subtypes in the hippocampus of the rat. Biochem. Biophysic. Research Commun., 106, 1134–1140

    Article  CAS  Google Scholar 

  • George, D. T., Adinoff, B., Ravitz, B., Nutt, D. J., De Jong, J., Berettini, W., Mefford, I. N., Costa, E. and Linnoila, M. (1989). A CSF study examining the pathophysiology associated with the comorbidity of panic disorder and alcoholism. Acta Psych. Scand., in press

    Google Scholar 

  • Giorgi, O., Corda, M. G., Fernandez, A. and Biggio, G. (1988). The abstinence syndrome in diazepam-dependent cats is precipitated by Ro 15-1788 and Ro 15-4513 but not by the benzodiazepine receptor antagonist ZK 93426. Nurosci. Lett., 88, 206–210

    Article  CAS  Google Scholar 

  • Glover, V., Halket, J. M., Watkins, P. J., Clow, A., Goodwin, B. L. and Sandler, M. (1988). Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. J. Neurochem., 51, 656–659

    Article  PubMed  CAS  Google Scholar 

  • Green, A. R., Nutt, D. J. and Cowen, P. C. (1982). Using Ro 15-1788 to investigate the benzodiazepine receptor in-vivo: Studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663. Psychopharmacology, 78, 293–295

    Article  PubMed  CAS  Google Scholar 

  • Grimm, G., Ferenci, P., Katzenschlager, R., Madl, C., Schneeweiss, B., Laggner, A. N., Lenz, K. and Gangl, A. (1988). Improvement of hepatic encephalopathy treated with flumazenil. Lancet, ii, 1392–1394

    Article  Google Scholar 

  • Guidotti, A., Forchetti, C. M., Corda, M. G., Konkel, D., Bennett, C. D. and Costa, E. (1983). Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl Acad. Sci. USA, 80, 3531–3535

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Haefely, W. (1988a). The preclinical pharmacology of flumazenil. Eur. Journal of Anaesthesiol., 2, 25–36

    CAS  Google Scholar 

  • Haefely, W. (1988b). Partial agonists of the benzodiazepine receptor: from animal data to results in patients. In Chloride Channels and Their Modulation by Neurotransmitters and Drugs (ed. G. Biggio and E. Costa), Raven Press, New York, pp. 275–292

    Google Scholar 

  • Haefely, W. (1988c). Endogenous ligands of the benzodiazepine receptor. Pharmacopsychiat., 21, 43–46

    Article  CAS  Google Scholar 

  • Haefely, W. and Hunkeler, W. (1988). The story of flumazenil. Eur. Journal of Anaesthesiol., 2, 3–14

    CAS  Google Scholar 

  • Haefely, W., Kyburz, E., Gerecke, M. and Mohler, H. (1985). Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure activity relationships of their agonists and antagonists. Adv. Drug Res., 14, 165–322

    CAS  Google Scholar 

  • Haefely, W. E. (1989). Pharmacology of the allosteric modulation of GABAa receptors by benzodiazepine receptor ligands. In Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications (ed. E. A. Barnard and E. Costa), Raven Press, New York, pp. 47–69

    Google Scholar 

  • Haigh, J. R. M. and Feely, M. (1988). RO 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice. Eur. J. Pharmacol., 147, 283–285

    Article  PubMed  CAS  Google Scholar 

  • Horton, R. W., Lowther, S., Chivers, J., Jenner, P., Marsden, C. D. and Testa, B. (1988). The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro. Br. J. Pharmacol., 94, 1234–1240

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hunkeler, W., Mohler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R. and Haefely, W. (1981). Selective antagonists of benzodiazepines. Nature, 290, 514–516

    Article  PubMed  CAS  Google Scholar 

  • Jackson, H. C., Dickinson, S. D. and Nutt, D. J. (1989). Differential effects of benzodiazepine inverse agonists on electroshock seizure threshold. BPS, Manchester (abstr.)

    Google Scholar 

  • Jensen, L. H., Petersen, E. N. and Braestrup, C. (1983). Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci., 33, 393–399

    Article  PubMed  CAS  Google Scholar 

  • Jensen, L. H., Petersen, E. N., Braestrup, C., Honore, T., Kehr, W., Stephens, D. N., Schneider, H., Seidelmann, D. and Schmiechen, R. (1984). Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist. Psychopharmacology, 83, 249–256

    Article  PubMed  CAS  Google Scholar 

  • Julou, L., Blanchard, J. C. and Dreyfus, J. F. (1985). Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone. Pharmacol. Biochem. Behavior, 23, 653–659

    Article  CAS  Google Scholar 

  • Karobath, M., Supavilai, P. and Borea, P. A. (1983). Distinction of benzodiazepine receptor agonists and inverse agonists by binding studies in vitro. In Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology (ed. G. Biggio and E. Costa), Raven Press, New York, pp. 37–45

    Google Scholar 

  • Keane, P. E., Bachy, A., Morre, M. and Biziere, K. (1988b). Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites. J. Pharmacol. Ex. Thera., 245, 699–705

    CAS  Google Scholar 

  • Keane, P. E., Simiand, J., Morre, M. and Biziere, K. (1988a). Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents. J. Pharmacol. Exp. Thera., 245, 692–698

    CAS  Google Scholar 

  • Kemp, J. A., Marshall, G. R., Wong, E. H. F. and Woodruff, G. N. (1987). The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABA(A)-receptors. Br. J. Pharmacol., 91, 601–608

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C. and Beer, B. (1979). Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol. Biochem. Behavior, 11, 457–462

    Article  CAS  Google Scholar 

  • Klockgether, T., Schwarz, M., Turski, L. and Sontag, K.-H. (1985). ZK 91296, an anticonvulsant (beta)-carboline which lacks muscle relaxant properties. Eur. J. Pharmacol., 110, 309–315

    Article  PubMed  CAS  Google Scholar 

  • Kumar, B. A., Forster, M. J. and Lal, H. (1988). CGS 8216, a benzodiazepine receptor antagonist, enhances learning and memory in mice. Brain Research, 460, 195–198

    Article  PubMed  CAS  Google Scholar 

  • Langer, S. Z. and Arbilla, S. (1988). Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacol. Biochem. Behavior, 29, 763–766

    Article  CAS  Google Scholar 

  • Le Fur, G., Mizoule, J., Burgevin, M. C., Ferris, O., Heaulme, M., Gauthier, A., Gueremy, C. and Uzan, A. (1981). Multiple benzodiazepine receptors: evidence of a dissociation between anticonflict and anticonvulsant properties by PK 9084 (two quinoline derivatives). Life Sci., 28, 1439–1448

    Article  PubMed  Google Scholar 

  • Le Fur, G., Perrier, M. L., Vaucher, N., Imbault, F., Flamier, A., Benavides, J., Uzan, A., Renault, C., Dubroeucq, M. C. and Gueremy, C. (1983). Peripheral benzodiazepine binding sites: effect of PK11195, 1-(2-chlorophenyl)-N-methyl-N-(l-methylpropyl)-3-isoquinoline-carboxamide. I. In vitro studies. Life. Sci., 32, 1839–1847

    Article  PubMed  Google Scholar 

  • Levi de Stein, M., Medina, J. H. and De Robertis, E. (1989) In vivo and in vitro modulation of central type benzodiazepine receptors by phosphotidylserine. Brain Res. Mol. Brain Res., 5, 9–15

    Article  Google Scholar 

  • Levitan, E. S., Schofield, P. R., Burt, D. R., Rhee, L. M., Wisden, W., Kohler, M., Fujita, N., Rodriguez, H. F., Stephenson, A., Darlison, M. G., Barnard, E. A. and Seeburg, P. H. (1988). Structural and functional basis for GABAa receptor heterogeneity. Nature, 335, 76–79

    Article  PubMed  CAS  Google Scholar 

  • Lippa, A. S., Coupet, J., Greenblatt, E. N., Klepner, C. A. and Beer, B. (1979). A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety. Pharmacol. Biochem. Behavior, 11, 99–106

    Article  CAS  Google Scholar 

  • Lister, R. G. and Karanian, J. (1987). Ro 15-4513 induces seizures in DBA/2 mice undergoing alcohol withdrawal. Alcohol, 4, 409–411

    Article  PubMed  CAS  Google Scholar 

  • Lister, R. G. (1988). Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety. Pharmacol. Biochem. Behavior, 30, 701–706

    Article  CAS  Google Scholar 

  • Lister, R. G. and Nutt, D. J. (1986). Mice and rats are sensitised to the proconvulsant actions of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam. Brain Res., 379, 364–366

    Article  PubMed  CAS  Google Scholar 

  • Lister, R. G. and Nutt, D. J. (1987). Is Ro 15-4513 a specific alcohol antagonist? Trends Neurosci., 10, 223–225

    Article  CAS  Google Scholar 

  • Little, H. J. and Bichard, A. R. (1984). Differential effects of the benzodiazepine antagonist Ro 15-1788 after ‘general anaesthetic’ doses of benzodiazepines in mice. Br. J. Anaes., 56, 1153–1160

    Article  CAS  Google Scholar 

  • Little, H. J. and Nutt, D. J. (1984). Benzodiazepine contragonists cause kindling. Br. J. Pharmac., 81, 28 (abstr.)

    Google Scholar 

  • Little, H. J., Gale, R., Sellars, N., Nutt, D. J. and Taylor, S. C. (1988). Chronic benzodiazepine treatment increases the effects of the inverse agonist FG 7142. Neuropharmacology, 27, 383–389

    Article  PubMed  CAS  Google Scholar 

  • Little, H. J., Nutt, D. J. and Taylor, S. C. (1984). Acute and chronic effects of the benzodiazepine receptor ligand FG7 7142: proconvulsant properties and kindling. Br. J. Pharmacol., 83, 951–958

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Little, H. J., Nutt, D. J. and Taylor, S. C. (1987). Kindling and withdrawal changes at the benzodiazepine receptor. J. Psychopharmacol., 1, 35–46

    Article  PubMed  CAS  Google Scholar 

  • Little, H. J., Taylor, S. C. and Nutt, D. J. (1985). The benzodiazepine antagonist Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats. Eur. J. Pharmacol., 107, 375–377

    Article  PubMed  CAS  Google Scholar 

  • Lo, M. M. S., Niehoff, D. L., Kuhar, M. J. and Snyder, S. H. (1983). Differential localization of type I and type II benzodiazepine binding sites in substantia nigra. Nature, 306, 57–60

    Article  PubMed  CAS  Google Scholar 

  • Lo, M. M. S., Strittmatter, S. M. and Snyder, S. H. (1982). Physical separation and characterization of two types of benzodiazepine receptors. Proc. Natl Acad. Sci. USA, 79, 680–684

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lukas, S. E. and Griffiths, R. R. (1984). Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur. J. Pharmacol., 100, 163–171

    Article  PubMed  CAS  Google Scholar 

  • Marley, R. J., Stinchcomb, A. and Wehner, J. M. (1988). Further characterization of benzodiazepine receptor differences in long-sleep and short-sleep mice. Life Sci., 43, 1223–1231

    Article  PubMed  CAS  Google Scholar 

  • Martin, I. L. and Doble, A. (1983). The benzodiazepine receptor in the rat brain and its interaction with ethyl (beta)-carboline-3-carboxylate. J. Neurochem., 40, 1613–1619

    Article  PubMed  CAS  Google Scholar 

  • Martin, J. R., Pieri, L., Bonetti, E. P., Schaffner, R., Burkard, W. P., Cumin, R. and Haefely, W. E. (1988a). Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiat., 21, 360–362

    Article  CAS  Google Scholar 

  • Martin, J. R., Schaffner, R., Pieri, L., Bonetti, E. P., Scherschlicht, R., Polc, P., Cumin, R. and Haefely, W. E. (1988b). Behavioral and electrophysiological effects of the thieno-quinolizinone putative anxiolytic Ro 19-5686. Eur. J. Neurosci., 18, 17 (abstr.)

    Google Scholar 

  • Mathers, D. A. and Yoshida, H. (1987). The benzodiazepine triazolam: direct and GABA depressant effects on cultured mouse spinal cord neurons. Eur. J. Pharmacol., 139, 53–60

    Article  PubMed  CAS  Google Scholar 

  • Matsushita, A., Kawasaki, K., Matsubara, K., Eigyo, M., Shindo, H. and Takada, S. (1988). Activation of brain function by S-135, a benzodiazepine receptor inverse agonist. Prog. Neuropsychopharmacol. Biol Psychi., 12, 951–966

    Article  CAS  Google Scholar 

  • McLean, M. J. and Macdonald, R. L. (1988). Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J. Pharmacol. Exp. Thera., 244, 789–795

    CAS  Google Scholar 

  • McNicholas, L. F. and Martin, W. R. (1982). The effect of a benzodiazepine antagonist, Ro 15-1788, in diazepam dependent rats. Life Sci., 31, 731–737

    Article  PubMed  CAS  Google Scholar 

  • Medina, J. H., Levi de Stein, M. and De Robertis, E. (1989). n-[3H]-Butyl-β-carboline-3-carboxylate, a putative endogenous ligand, binds preferentially to subtype 1 of central benzodiazepine receptors. J. Neurochem., 52, 665–670

    Article  PubMed  CAS  Google Scholar 

  • Mehta, A. K. and Ticku, M. J. (1989). Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chloride channels in mammalian cultured spinal cord neurons. J. Pharmacol. Exp. Thera., 249, 418–423

    CAS  Google Scholar 

  • Melchior, C. L., Garrett, K. M. and Tabakoff, B. (1984). A benzodiazepine antagonist action of CL 218,872. Life Sci., 34, 2201–2206

    Article  PubMed  CAS  Google Scholar 

  • Miller, L. G., Greenblatt, D. J., Barnhill, J. G., Deutsch, S. I,, Shader, R. I. and Paul, S. M. (1987). Benzodiazepine receptor binding of triazolobenzodiazepine in vivo: increased receptor number with low-dose alprazolam. J. Neurochem., 49, 1595–1601

    Article  PubMed  CAS  Google Scholar 

  • Minchin, M. C. W. and Nutt, D. J. (1983). Studies on [3H]-diazepam and [3H]-ethyl-β-carboxylate binding to rat brain in vivo. I. Regional variations in displacement. J. Neurochem., 41, 1507–1512

    Article  PubMed  CAS  Google Scholar 

  • Mitchell, P. R. and Martin, I. L. (1978). Is GAB A release modulated by presynaptic receptors? Nature, 274, 904–905

    Article  PubMed  CAS  Google Scholar 

  • Mohler, H. and Okada, T. (1978). The benzodiazepine receptor in normal and pathological human brain. Br. J. Psychiat., 133, 261–268

    Article  CAS  Google Scholar 

  • Mohler, H. (1981). Benzodiazepine receptors: are there endogenous ligands in the brain? TIPS, 2, 116–119

    Google Scholar 

  • Mohler, H., Malherbe, P., Sequier, J. M., Bannwarth, W., Schoch, P. and Richards, J. G. (1989). Location, structure, and sites of synthesis of the GABAa receptor in the central nervous system. In Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications (ed. E. A. Barnard and E. Costa), Raven Press, New York, pp. 31–46

    Google Scholar 

  • Nagy, A. and Lajtha, A. (1983). Thyroid hormones and derivatives inhibit flunitrazepam binding. J. Neurochem., 40, 414–417

    Article  PubMed  CAS  Google Scholar 

  • Nicholson, A. N. and Pascoe, D. A. (1986). Hypnotic activity of an imidazo-pyridine (Zolpidem). Br. J. Clin. Pharmacol., 21, 205–211

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Niddam, R., Dubois, A., Scatton, B., Arbilla, S. and Langer, S. Z. (1987). Autoradiographic localization of [3H]-zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites. J. Neurochem., 49, 890–899

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, E. B., Jepsen, S. A., Nielsen, M. and Braestrup, C. (1985). Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM) an inverse agonist at benzodiazepine receptors. Life Sci., 36, 15–23

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, M. and Braestrup, C. (1980). Ethyl-β-carboline-3-carboxylate shows differential benzodiazepine receptor interaction. Nature, 286, 606–607

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, M., Braestrup, C. and Squires, R. F. (1978). Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Research, 141, 342–346

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, M., Frokjaer, S. and Braestrup, C. (1988a). High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochem. Pharmacol., 37, 3285–3287

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, M., Gredal, O. and Braestrup, C. (1979). Some properties of 3H-diazepam-reversing effects of ethyl-β-carboline-3-carboxylate. Life Sci., 25, 679–686

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, M., Witt, M. R. and Thogersen, H. (1988b). [3H]diazepam specific binding to rat cortex in vitro is enhanced by oleic, arachidonic and docosahexenoic acid isolated from pig brain. Eur. J. Pharmacol., 146, 349–353

    Article  PubMed  CAS  Google Scholar 

  • Ninan, P. T., Insel, T. M., Cohen, R. M., Cook, J. M., Skolnick, P. and Paul, S. M. (1982). Benzodiazepine receptor-mediated experimental ‘anxiety’ in primates. Science, 218, 1332–1334

    Article  PubMed  CAS  Google Scholar 

  • Nutt, D. J. (1983). Pharmacological and behavioural studies on benzodiazepine antagonists and contragonists. In Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology (ed. G. Biggio and E. Costa), Raven Press, New York, pp. 153–173

    Google Scholar 

  • Nutt, D. J. (1986). Benzodiazepine dependence in the clinic: reason for anxiety. Trends Pharmacol. Sci., 7, 457–460

    Article  CAS  Google Scholar 

  • Nutt, D. J. (1988a). Benzodiazepine terminology. TIPS, 9, 86 (letter)

    PubMed  CAS  Google Scholar 

  • Nutt, D. J. (1988b). Benzodiazepine receptor ligands. Neurotransmissions, 4, no. 2

    Google Scholar 

  • Nutt, D. J. (1990). The pharmacology of human anxiety. Pharmacol. Ther., in press

    Google Scholar 

  • Nutt, D. J. and Costello, M. (1988). Rapid induction of lorazepam dependence and its reversal with flumazenil. Life Sci., 43, 1045–1053

    Article  PubMed  CAS  Google Scholar 

  • Nutt, D. J., Cowen, P. C. and Little, H. J. (1982). Unusual interactions of benzodiazepine receptor antagonists. Nature, 295, 436–438

    Article  PubMed  CAS  Google Scholar 

  • Nutt, D. J. and Lister, R. G. (1987). The effect of the imidazodiazepine Ro 15-4513 on the anticonvulsant effects of diazepam, sodium pentobarbitol and ethanol. Brain Res., 413, 193–196

    Article  PubMed  CAS  Google Scholar 

  • Nutt, D. J. and Lister, R. G. (1988). Strain differences in the response to the benzodiazepine receptor inverse agonist (FG 7142) in mice. Psychopharmacology, 94, 435–436

    Article  Google Scholar 

  • Nutt, D. J. and Lister, R. G. (1989a). 3-(methoxycarbonyl)-amino-β-carboline reduces both the sedative and anticonvulsant effects of diazepam. Eur. J. Pharmacol., 165, 135–138

    Article  PubMed  CAS  Google Scholar 

  • Nutt, D. J. and Lister, R. G. (1989b). Antagonizing the anticonvulsant effect of ethanol using drugs that act at the benzodiazepine/GABA receptor complex. Pharmacol. Biochem. Behavior, 31, 751–755

    Article  Google Scholar 

  • Nutt, D. J. and Little, H. J. (1986). Benzodiazepine-receptor mediated convulsions in infant rats: effects of beta-carbolines. Pharmacol. Biochem. Behavior, 24, 841–844

    Article  CAS  Google Scholar 

  • Nutt, D. J., Little, H. J., Taylor, S. C. and Minchin, M. C. W. (1984). Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM. Eur. J. Pharmacol., 103, 359–362

    Article  PubMed  CAS  Google Scholar 

  • Nutt, D. J. and Glue, P. (1989). Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharm. Ther., 44, 309–334

    Article  CAS  Google Scholar 

  • Nutt, D. J., Glue, P. and Lawson, C. L. (1989). The neurochemistry of anxiety: an update. Prog. Neuro-Psychopharmacol. Biol Psychiat., in press

    Google Scholar 

  • Nutt, D. J. and Minchin, M. C. W. (1983). Studies on [3H]-diazepam and [3H]-ethyl-β-carboxylate binding to rat brain in vivo. II. Effects of electroconvulsive shock. J. Neurochem., 41, 1513–1517

    Article  PubMed  CAS  Google Scholar 

  • Oakley, N. R. and Jones, B. J. (1980). The proconvulsant and diazepam-reversing effects of ethyl-β-carboline-3-carboxylate. Eur. J. Pharmacol., 68, 381–382

    Article  PubMed  CAS  Google Scholar 

  • Oakley, N. R. and Jones, B. J. (1982). Differential pharmacological effects of β-carboline-3-carboxylic acid esters. Neuropharmacology, 21, 587–589

    Article  PubMed  CAS  Google Scholar 

  • Oakley, N. R., Jones, B. J. and Straughan, D. W. (1984). The benzodiazepine receptor ligand CL 218,872 has both anxiolytic and sedative properties in rodents. Neuropharmacol., 23, 797–802

    Article  CAS  Google Scholar 

  • Obata, T. and Yamamura, H. I. (1988). Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by triazolobenzodiazepines. Life Sci., 42, 659–665

    Article  PubMed  CAS  Google Scholar 

  • Olasma, M., Guidotti, A., Costa, E., Rothstein, J. D., Goldman, M. E., Weber, R. J. and Paul, S. M. (1989). Endogenous benzodiazepine in hepatic encephalopathy. Lancet, i, 491–492

    Article  Google Scholar 

  • Olsen, R. W. (1981). GABA-benzodiazepine-barbiturate receptor interactions. J. Neurochem., 37, 1–13

    Article  PubMed  CAS  Google Scholar 

  • Perrault, G., Morel, E., Sanger, D. J. and Zivkovic, B. (1988). The interaction between Zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of Zolpidem. Eur. J. Pharmacol., 156, 189–196

    Article  PubMed  CAS  Google Scholar 

  • Persson, A., Pauli, S., Swahn, C. G., Halldin, C. and Sedvall, G. (1989). Cerebral uptake of [11C]-Ro 15-1788 and its acid metabolite [11C]-Ro 15-3890; PET study in healthy volunteers. Human Psychopharm., 4, 215–220

    Article  CAS  Google Scholar 

  • Petersen, E. N., Jensen, L. H., Honore, T. and Braestrup, C. (1983). Differential pharmacological effects of benzodiazepine receptor inverse agonists. In Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology (ed. G. Biggio and E. Costa), Raven Press, New York, pp. 57–64

    Google Scholar 

  • Petersen, E. N. (1987). Benzodiazepine receptor pharmacology: new vistas. Drugs Fut., 12, 1043–1053

    Google Scholar 

  • Petersen, E. N. and Jensen, L. H. (1987). Lorazepam and FG 7142 induce tolerance to the DMCM antagonistic effect of benzodiazepine receptor ligands. Brain Res. Bull., 19, 387–391

    Article  PubMed  CAS  Google Scholar 

  • Petursson, H., Bhattacharya, S. K., Glover, V., Sandler, M. and Lader, M. H. (1982). Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br. J. Psychiat., 140, 7–10

    Article  CAS  Google Scholar 

  • Pieri, L. (1988). Ro 19-4603: a benzodiazepine receptor partial inverse agonist with prolonged proconvulsant action in rodents. Br. J. Pharmacol., 95, 477 (abstr.)

    Google Scholar 

  • Pieri, L., Biry, P. and Wdonwicki, G. (1985). Proconvulsant action of Ro 15-3505, the 7-chloro analogue of Ro 15-1788, on isoniazid convulsions in rats. Br. J. Pharmacol, 86, 592

    Google Scholar 

  • Polc, P., Bonetti, E. P., Schaffner, R. and Haefely, W. (1982). A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquillizers, β-carbolines, and phenobarbitone. Naunyn-Schmiedeberg’s Arch. Pharmacol., 321, 260–264

    Article  CAS  Google Scholar 

  • Potier, M. C., Prado de Carvalho, L., Dodd, R. H., Besselievre, R. and Rossier, J. (1988a). In vivo binding of β-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects. Mol. Pharmacol., 34, 124–128

    PubMed  CAS  Google Scholar 

  • Potier, M. C., Prado de Carvalho, L., Venault, P., Chapouthier, G. and Rossier, J. (1988b). Demonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivo. Eur. J. Pharmacol., 156, 169–172

    Article  PubMed  CAS  Google Scholar 

  • Potier, M. C., Prado de Carvalho, L., Dodd, R. H., Brown, C. L. and Rossier, J. (1988c). In vivo binding of [3H]Ro 15-1788 in mice: comparison with the in vivo binding of [3H]flunitazepam. Life Sci., 43, 1287–1296

    Article  PubMed  CAS  Google Scholar 

  • Prado de Carvalho, L., Venault, P., Potier, M. C., Dodd, R. H., Brown, C. L., Chapouthier, G. and Rossier, J. (1986). 3-(methoxycarbonyl)-amino-β-carboline, a selective antagonist of the sedative effects of benzodiazepines. Eur. J. Pharmacol., 129, 323–332

    Article  Google Scholar 

  • Pratt, J. A., Brett, R. R. and Laurie, D. J. (1989). Local cerebral glucose utilization after intraventricular administration of octadecaneuropeptide (‘anxiety peptide’). J. Cerebr. Blood Flow Metab., 9, S682

    Google Scholar 

  • Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R. and Seeburg, P. H. (1989a). Importance of a novel GABA(A) receptor subunit for benzodiazepine pharmacology. Nature, 338, 582–585

    Article  PubMed  CAS  Google Scholar 

  • Pritchett, D. B., Luddens, H. and Seeburg, P. H. (1989b). Type I and type II GABA(A)-benzodiazepine receptors produced in transfected cells. Science, 245, 1389–1392

    Article  PubMed  CAS  Google Scholar 

  • Robertson, H. A., Baker, G. B., Coutts, R. T., Benderly, A., Locock, R. A. and Martin, I. L. (1981). Interactions of β-carbolines with the benzodiazepine receptor: structure-activity relationships. Eur. J. Pharmacol., 76, 281–284

    Article  PubMed  CAS  Google Scholar 

  • Rodgers, R. J., Waters, A. J. and Rosenfield, S. (1983). Evidence for intrinsic behavioural activity of the benzodiazepine antagonist, Ro 15-1788, in male mice. Pharmacol. Biochem. Behav., 19, 895–898

    Article  PubMed  CAS  Google Scholar 

  • Romer, D., Buscher, H. H., Hill, R. C., Maurer, R. and Petcher, T. J. (1982). An opioid benzodiazepine. Nature, 298, 759–760

    Article  PubMed  CAS  Google Scholar 

  • Rommelspacher, H., Barbey, M., Strauss, S., Greiner, B. and Fahndrich, E. (1982). Is there a correlation between the concentration of beta-carbolines and their pharmacodynamic effects? In β-carbolines and Tetrahydroisoquinolones, (Eds F. Bloom et al.), Liss, New York

    Google Scholar 

  • Sandler, M. (1982). The emergence of tribulin. TIPS, 3, 471–472

    CAS  Google Scholar 

  • Sangameswaran, L. and De Blas, A. L. (1985). Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines. Proc. Natl Acad. Sci. USA, 82, 5560–5564

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sangameswaran, L., Fales, H. M., Friedrich, P. and De Blas, A. L. (1986). Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. Proc. Natl Acad. Sci. USA, 83, 9236–9240

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sarter, M., Bodewitz, G. and Stephens, D. N. (1988). Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacol., 94, 491–495

    Article  CAS  Google Scholar 

  • Sarter, M. and Stephens, D. N. (1989). Disinhibitory properties of β-carboline antagonists of benzodiazepine receptors: a possible therapeutic approach for senile dementia? Biochem. Soc. Transactions, 17, 81–83

    Article  CAS  Google Scholar 

  • Schaffner, R., Martin, J. R. and Haefely, W. E. (1988). The benzodiazepine receptor (BZR) partial agonist Ro 19-5686, a novel putative anxiolytic, exhibits lower ethanol potentiation and dependence potential than BZR full agonists. Eur. J. Neurosci., 18, 18 (abstr.)

    Google Scholar 

  • Schneider, H. H. and Stephens, D. N. (1988). Coexistence of kindling induced by the β-carboline, FG 7142, and tolerance to diazepam following chronic treatment in mice. Eur. J. Pharmacol., 154, 35–45

    Article  PubMed  CAS  Google Scholar 

  • Schoch, P., Richards, J. G., Haring, P., Takacs, B., Stahli, C., Staehelin, T., Haefely, W. and Mohler, H. (1985). Co-localization of GABA(A) receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature, 314, 168–171

    Article  PubMed  CAS  Google Scholar 

  • Schofield, P. R., Darlison, M. G., Gujita, N., Burt, D. R., Stephenson, F. A., Rodriguez, H., Rhee, L. M., Ramachandran, J., Reale, V., Glencorse, T. A., Seeburg, P. H. and Barnard, E. A. (1987). Sequence and functional expression of the GABA-A receptor shows a ligand gated super family. Nature, 328, 221

    Article  PubMed  CAS  Google Scholar 

  • Scollo-Lavizzari, G. (1984). The anticonvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases. Eur. Neurol., 23, 1–6

    Article  PubMed  CAS  Google Scholar 

  • Sequier, J. M., Richards, J. G., Malherbe, P., Price, G. W., Mathews, S. and Mohler, H. (1988). Mapping of brain areas containing RNA homologous to cDNAs encoding the α and β subunits of the rat GABAA gamma-aminobutyrate receptor Proc. Natl Acad. Sci. USA, 85, 7815–7819

    Article  CAS  Google Scholar 

  • Shannon, H. E., Guzman, F. and Cook, J. M. (1984). β-carboline-3-carboxylate-t-butyl ester: a selective BZ1 benzodiazepine receptor antagonist. Life Sci., 35, 2227–2236

    Article  PubMed  CAS  Google Scholar 

  • Shannon, H. E. and Katzman, N. J. (1986). CGS 8216: agonist and diazepam-antagonist effects in rodents. J. Pharmacol. Exp. Thera., 239, 166–173

    CAS  Google Scholar 

  • Sieghart, W. (1983). Several new benzodiazepines selectively interact with a benzodiazepine receptor subtype. Neurosci. Lett., 38, 73–78

    Article  PubMed  CAS  Google Scholar 

  • Sieghart, W. (1987). Multiple benzodiazepine binding sites. In GABA and Benzodiazepine Receptors, vol. II (ed. R. F. Squires), CRC Press, USA, pp. 1–14

    Google Scholar 

  • Sieghart, W. and Drexler, G. (1983). Irreversible binding of [3H]flunitrazepam to different proteins in various brain regions. J. Neurochem., 41, 47–55

    Article  PubMed  CAS  Google Scholar 

  • Sieghart, W. and Karobath, M. (1980). Molecular heterogeneity of benzodiazepine receptors. Nature, 286, 285–287

    Article  PubMed  CAS  Google Scholar 

  • Simmonds, M. A. (1980). A site for the potentiation of GABA-mediated responses by benzodiazepines. Nature, 284, 558–560

    Article  PubMed  CAS  Google Scholar 

  • Simmonds, M. A. (1984). Physiological and pharmacological characterization of the actions of GABA. In Actions and Interactions of GABA and Benzodiazepines (ed. N. G. Bowery), Raven Press, New York, pp. 27–43

    Google Scholar 

  • Snyder, S. H., Enna, S. J. and Young, A. B. (1978). Brain mechanisms associated with therapeutic actions of benzodiazepines: focus on neurotransmitters. Am. J. Psych., 134, 662–664

    Google Scholar 

  • Squires, R. F. (1983). Benzodiazepine receptor multiplicity. Neuropharmacology, 22, 1443–1450

    Article  PubMed  CAS  Google Scholar 

  • Squires, R. F. and Braestrup, C. (1977). Benzodiazepine receptors in rat brain. Nature, 266, 732–734

    Article  PubMed  CAS  Google Scholar 

  • Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V. and Beer, B. (1979). Some properties of brain specific benzodiazepine receptor: new evidence for multiple receptors. Pharmacol. Biochem. Behavior, 10, 825–830

    Article  CAS  Google Scholar 

  • Steiner-Chaskel, N. and Lader, M. H. (1981). Effects of single doses of clobazam and diazepam on psychological functions in normal subjects. Royal Society of Medicine International Congress and Symposium Series, 43, 23–32

    CAS  Google Scholar 

  • Study, R. E. and Barker, J. L. (1981). Diazepam and [-]-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurones. Proc. Natl Acad. Sci. USA, 78, 7180–7184

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Suzdak, P. D., Glowa, J. R., Crawley, J. N., Schwartz, R. D., Skolnick, P. and Paul, S. M. (1986). A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science, 234, 1243–1247

    Article  PubMed  CAS  Google Scholar 

  • Sweetnam, P. M. and Tallman, J. F. (1985). Regional differences in brain benzodiazepine receptor carbohydrates. Mol. Pharmacol., 29, 299–306

    Google Scholar 

  • Taylor, S. C., Little, H. J., Nutt, D. J. and Sellars, N. (1985). A benzodiazepine agonist contragonist have hypothermic effects in rodents. Neuropharmacol., 24, 69–73

    Article  CAS  Google Scholar 

  • Tenen, S. S. and Hirsch, J. D. (1980). β-carboline-3-carboxylic acid ethyl ester antagonizes diazepam activity. Nature, 288, 609–610

    Article  PubMed  CAS  Google Scholar 

  • Thiebot, M. H., Soubrie, P. and Sanger, D. (1988). Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls. Psychopharmacol., 94, 452–463

    Article  CAS  Google Scholar 

  • Ticku, M. K. (1983). Benzodiazepine-GABA receptor-ionophore complex: Current concepts. Neuropharmacology, 22:12B, 1459–1470

    Article  PubMed  CAS  Google Scholar 

  • Trifiletti, R. R., Snowman, A. M. and Snyder, S. H. (1985). Barbiturate recognition site on the GABA/benzodiazepine receptor complex is distinct from the picrotoxinin/TBPS recognition site. Eur. J. Pharmacol., 106, 441–447

    Article  Google Scholar 

  • Trullas, R., Ginter, H., Jackson, B., Skolnick, P., Allen, M. S., Hagen, T. J. and Cook, J. M. (1988). 3-ethoxy-beta-carboline: a high affinity benzodiazepine receptor ligand with partial inverse agonist properties. Life Sci., 43, 1189–1197

    Article  PubMed  CAS  Google Scholar 

  • Trullas, R., Ginter, H. and Skolnick, P. (1987). A benzodiazepine receptor inverse agonist inhibits stress-induced ulcer formation. Pharmacol. Biochem. Behavior, 27, 35–39

    Article  CAS  Google Scholar 

  • Turner, D. M., Ransom, R. W., Yang, J. S. J. and Olsen, R. W. (1989). Steroid anesthetics and naturally occurring analogs modulate the (gama)-aminobutyric acid receptor complex at a site distinct from barbiturates. J. Pharmacol. Exp. Ther., 248, 960–966

    PubMed  CAS  Google Scholar 

  • Unseld, E., Krishna, D. R., Fischer, C. and Klotz, U. (1988). Endogenous benzodiazepines in brain right or wrong? Tins, 11, 490

    PubMed  CAS  Google Scholar 

  • Vellucci, S. V. and Webster, R. A. (1983). Is Ro15-1788 a partial agonist at benzodiazepine receptors? Eur. J. Pharmacol., 90, 263–268

    Article  PubMed  CAS  Google Scholar 

  • Venault, P., Chapouthier, G., Prado de Carvalho, L., Simiand, J., Morre, M., Dodd, R. H. and Rossier, J. (1986). Benzodiazepine impairs and (beta)-carboline enhances performance in learning and memory tasks. Nature, 321, 864–866

    Article  PubMed  CAS  Google Scholar 

  • Wildmann, J., Mohler, H., Vetter, W., Ranalder, U., Schmidt, K. and Maurer, R. (1987). Diazepam and N-desmethyldiazepam are found in rat brain and adrenal and may be of plant origin. J. Neural Transm., 70, 383–398

    Article  PubMed  CAS  Google Scholar 

  • Wildmann, J. and Ranalder, U. (1988). Presence of lorazepam in the blood plasma of drug free rats. Life Sci., 43, 1257–1260

    Article  CAS  Google Scholar 

  • Wildmann, J. (1988). Increase of natural benzodiazepines in wheat and potato during germination. Biochem. Biophys. Res. Commun., 157, 1436–1443

    Article  PubMed  CAS  Google Scholar 

  • Willer, J. C., Von Frenkell, R., Bonnet, D. and Le Fur, G. (1986). The ability of PK 8165, a quinoline derivative, to reduce responses to a stressful situation in a double-blind study in man. Neuropharmacol., 25, 275–281

    Article  CAS  Google Scholar 

  • Williams, E. F., Rice, K. C., Paul, S. M. and Skolnick, P. (1980). Heterogeneity of benzodiazepine receptor in the central nervous system demonstrated with kenazepine, an alkylating benzodiazepine. J. Neurochem., 35, 591–597

    Article  PubMed  CAS  Google Scholar 

  • Williams, M. (1984). Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics: a hypothetical allosteric model of the benzodiazepine receptor complex. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 8, 209–247

    Article  CAS  Google Scholar 

  • Williams, M., Bennett, D. A., Loo, P. S., Braunwalder, A. F., Amrick, C. L., Wilson, D. E., Thompson, T. N., Schmutz, M., Yokoyoma, N. and Wasley, J. W. F. (1989). CGS 20625, a novel pyrazolopyridine anxiolytic. J. Pharmacol. Exp. Ther., 248, 89–96

    PubMed  CAS  Google Scholar 

  • Williams, M. and Yokoyoma, N. (1986). Anxiolytics, anticonvulsants and sedative-hypnotics. In Annual Reports in Medicinal Chemistry (ed. D. M. Bailey, B. Hesp, J. A. Bristol, F. C. Sciavolino, B. A. Pawson, R. W. Egan and R. C. Allen), Academic Press, Orlando, pp. 11–20

    Google Scholar 

  • Wood, P. L., Loo, P., Braunwalder, A. and Cheney, D. L. (1984). In vitro characterization of agonist, antagonist, inverse agonist and agonist/antagonist benzodiazepines. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 8, 785–788

    Article  CAS  Google Scholar 

  • Woolf, J. H. and Nixon, J. C. (1981). Endogenous effector of the benzodiazepine binding site: purification and characterization. Biochemistry, 20, 4263–4269

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, School of Medical Sciences, University Walk, Bristol, Bristol BS8 1TD,, UK

    David Nutt (Reckitt and Colman Psychopharmacology Unit)

Authors
  1. David Nutt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, OX2 6AW, UK

    Neville N. Osborne

Copyright information

© 1990 Macmillan Publishers Limited

About this chapter

Cite this chapter

Nutt, D. (1990). Selective Ligands for Benzodiazepine Receptors: Recent Developments. In: Osborne, N.N. (eds) Current Aspects of the Neurosciences. Palgrave, London. https://doi.org/10.1007/978-1-349-11922-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-11922-6_9

  • Publisher Name: Palgrave, London

  • Print ISBN: 978-1-349-11924-0

  • Online ISBN: 978-1-349-11922-6

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation